Healthcare provider profile · identity verified

Shalan Joseph, NP

Nurse Practitioner · BRONX, NY · NPI 1407208150

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	378	94
Amlodipine Besylate	Amlodipine Besylate	254	56
Furosemide	Furosemide	221	48
Gabapentin	Gabapentin	176	37
Levothyroxine Sodium	Levothyroxine Sodium	175	47
Mirtazapine	Mirtazapine	171	44
Metoprolol Succinate	Metoprolol Succinate	153	32
Donepezil Hcl	Donepezil Hcl	135	27
Lisinopril	Lisinopril	130	27
Metformin Hcl	Metformin Hcl	117	30
Ciclopirox	Ciclopirox Olamine	116	37
Tamsulosin Hcl	Tamsulosin Hcl	113	26
Escitalopram Oxalate	Escitalopram Oxalate	111	23
Eliquis	Apixaban	104	33
Pantoprazole Sodium	Pantoprazole Sodium	97	30
Hydralazine Hcl	Hydralazine Hcl	95	21
Metoprolol Tartrate	Metoprolol Tartrate	94	33
Januvia	Sitagliptin Phosphate	90	19
Lactulose	Lactulose	89	27
Losartan Potassium	Losartan Potassium	86	24
Montelukast Sodium	Montelukast Sodium	84	12
Omeprazole	Omeprazole	80	20
Rosuvastatin Calcium	Rosuvastatin Calcium	78	18
Famotidine	Famotidine	75	15
Ipratropium Bromide	Ipratropium Bromide	66	suppressed
Levetiracetam	Levetiracetam	66	15
Trazodone Hcl	Trazodone Hcl	66	suppressed
Carvedilol	Carvedilol	63	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	17
Carbidopa-Levodopa	Carbidopa/Levodopa	60	13
Sertraline Hcl	Sertraline Hcl	58	suppressed
Memantine Hcl	Memantine Hcl	57	12
Finasteride	Finasteride	56	11
Nystop	Nystatin	54	17
Clopidogrel	Clopidogrel Bisulfate	51	16
Entresto	Sacubitril/Valsartan	51	suppressed
Simvastatin	Simvastatin	50	suppressed
Lorazepam	Lorazepam	48	16
Jardiance	Empagliflozin	47	13
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	44	21
Nifedipine Er	Nifedipine	44	13
Alendronate Sodium	Alendronate Sodium	43	suppressed
Insulin Aspart Flexpen	Insulin Aspart	42	11
Olanzapine	Olanzapine	41	suppressed
Potassium Chloride	Potassium Chloride	41	suppressed
Latanoprost	Latanoprost	38	17
Triamcinolone Acetonide	Triamcinolone Acetonide	38	suppressed
Ketoconazole	Ketoconazole	36	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	34	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	34	34
Tradjenta	Linagliptin	33	suppressed
Hydrocortisone	Hydrocortisone	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Lumigan	Bimatoprost	30	suppressed
Spironolactone	Spironolactone	30	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	28	16
Brimonidine Tartrate	Brimonidine Tartrate	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	27	12
Allopurinol	Allopurinol	26	suppressed
Nystatin	Nystatin	26	13
Rivastigmine	Rivastigmine	26	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	25	suppressed
Albuterol Sulfate	Albuterol Sulfate	24	suppressed
Baclofen	Baclofen	24	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	11
Risperidone	Risperidone	24	suppressed
Admelog Solostar	Insulin Lispro	23	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	12
Clonidine Hcl	Clonidine Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	22	suppressed
Methimazole	Methimazole	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Divalproex Sodium	Divalproex Sodium	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	20	11
Aripiprazole	Aripiprazole	19	suppressed
Diazepam	Diazepam	19	suppressed
Memantine Hcl Er	Memantine Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Glipizide	Glipizide	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	18	suppressed
Amantadine	Amantadine Hcl	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Repaglinide	Repaglinide	17	suppressed
Timolol Maleate	Timolol Maleate	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Clonidine	Clonidine	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Pregabalin	Pregabalin	16	suppressed
Rhopressa	Netarsudil Mesylate	16	suppressed
Ceftriaxone	Ceftriaxone Sodium	15	13
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clonazepam	Clonazepam	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	12
Simbrinza	Brinzolamide/Brimonidine Tart	13	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Exemestane	Exemestane	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Prednisone	Prednisone	12	suppressed
Rocklatan	Netarsudil Mesylat/Latanoprost	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Sodium Chloride	0.9 % Sodium Chloride	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error